Total submissions: 3
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV002000671 | SCV002274409 | uncertain significance | not provided | 2022-10-11 | criteria provided, single submitter | clinical testing | In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. Advanced modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) performed at Invitae indicates that this missense variant is not expected to disrupt GALNT12 protein function. ClinVar contains an entry for this variant (Variation ID: 1481954). This variant has not been reported in the literature in individuals affected with GALNT12-related conditions. This variant is present in population databases (rs374578939, gnomAD 0.0009%). This sequence change replaces arginine, which is basic and polar, with lysine, which is basic and polar, at codon 282 of the GALNT12 protein (p.Arg282Lys). |
Ambry Genetics | RCV004042471 | SCV002680606 | uncertain significance | not specified | 2021-08-14 | criteria provided, single submitter | clinical testing | The p.R282K variant (also known as c.845G>A), located in coding exon 4 of the GALNT12 gene, results from a G to A substitution at nucleotide position 845. The arginine at codon 282 is replaced by lysine, an amino acid with highly similar properties. This amino acid position is conserved. In addition, the in silico prediction for this alteration is inconclusive. Since supporting evidence is limited at this time, the clinical significance of this alteration remains unclear. |
Baylor Genetics | RCV004571888 | SCV005058818 | uncertain significance | Colorectal cancer, susceptibility to, 1 | 2024-02-08 | criteria provided, single submitter | clinical testing |